Home » Topics » Regulatory » Patents

Patents
RSS

LTB4 antagonists from Pfizer

June 14, 1996

More glutamate antagonists from NeuroSearch

June 14, 1996

Novo Nordisk synthesizes AMPA antagonists

June 14, 1996

Glutamate antagonists reported by BASF

June 14, 1996

Warner-Lambert discloses complement C1r protease inhibitors

June 14, 1996

Polypeptides with neuroprotective/neurotrophic activity

June 14, 1996

Cephalon research reveals active compounds

June 14, 1996

Lilly reports metabotropic glutamate receptor antagonists

June 14, 1996

SmithKline Beecham describes 5-HT1D antagonists

June 14, 1996

Compounds with melatonin receptor affinity from Takeda

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.